Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal mRNA-1273 Patch for COVID-19 Revaccination (MILESTONE)
NCT05315362Phase 2Unknown
- Sponsor
- Leiden University Medical Center
- Start
- May 2022
- Primary completion
- Sep 2022
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of elasomeran in coronavirus disease 2019 (COVID-19), sponsored by Leiden University Medical Center. Status: unknown.
02
Drugs
elasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05315362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05315362.